Insider trades
Robin Shane Readnour, Director of AN2 Therapeutics ANTX, has filed 14 purchases and 4 sales on the open market. The latest trade was on 03/19.
Robin Shane Readnour
Director
- Company
- AN2 Therapeutics ANTX
- First filing
- 23/06/09
- Trades
- 27 trades
- Buys / sales
- 14 / 4
- 12-month net buying
- No record
- Last trade
- 03/19
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
ANTX | Open-market buy | 24/12/06–24/12/10 | 24/12/10 | 60,000 sh6 trades | $1.45avg. | $86,784.56 | +10.1% |
ANTX | Open-market buy | 24/11/26–24/11/27 | 24/11/27 | 75,000 sh4 trades | $1.41avg. | $105,750 | +13.7% |
ANTX | Open-market buy | 24/11/19–24/11/20 | 24/11/21 | 200,000 sh4 trades | $1.07avg. | $213,000 | +63.5% |
ANTX | Open-market sale10b5-1 plan | 24/01/12 | 24/01/17 | 1,425 sh2 trades | $21.91avg. | $31,228.81 | −0.3% |
ANTX | Open-market sale10b5-1 plan | 24/01/10 | 24/01/12 | 3,669 sh2 trades | $21.93avg. | $80,443.17 | −0.7% |